Efficacy Evaluation of Nano-Luliconazole in Patients with Treatment-Resistant Dermatophytosis

Efficacy Evaluation of Loaded Nanostructured Lipid Carriers (NLC) with Luliconazole in Treatment-Resistant Dermatophytosis

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240711062393N1

Enrollment

Registered

2024-07-25

Start date

2024-08-10

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatophytosis is an inflammatory skin infection caused by dermatophyte fungi including Trichophyton, Microsporum, Epidermophyton, Lophophyton, Nannizzia, Parathion, and Arthroderma.. Dermatophytosis

Interventions

Intervention 1: Intervention group: The first group includes patients resistant to dermatophytosis other than onychomycosis who take NLC g

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with treatment-resistant dermatophytosis

Exclusion criteria

Exclusion criteria: Neonates and children range from 0 to 19 years pregnant mothers

Design outcomes

Primary

Measure	Time frame
Individuals with treatment-resistant dermatophytosis. Timepoint: Patients are evaluated after 2 and 4 weeks of treatment. Method of measurement: Assessing improvement, lesion size, itch, and inflammation based on the questionnaire's scoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Abastabar

Mazandaran University of Medical Sciences

mabastabar@gmail.com+98 11 3304 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026